Super Micro Computer Inc. (SMCI)

Super Micro Computer Inc. (SMCI) has fallen 31.68% over the past month and sits near the bottom of its 52-week range, even though its latest quarter beat estimates. The stock was down 5.70% in the first session after the November 3, 2026 report, the quarter in which EPS came in at $1.81 against a $1.23 estimate. Revenue grew 297.50% year on year, yet the shares trade at a trailing P/E of 6.07, far below the sector median of 35.1. The gap between strong reported results and a sagging price is the central question for the stock now.

Super Micro beat EPS estimates in four of the last five reported quarters. The November 3, 2026 report delivered $1.81 against a $1.23 estimate, a beat of 47.15%, yet the stock fell 5.70% in the first session afterwards. It was the only one of the four beats that was followed by a lower share price. Earlier beats in August and May were rewarded with gains of 19.02% and 24.54%, so the market's reaction has shifted from enthusiasm to scepticism even as the reported numbers improved.

At a trailing P/E of 6.07 and a price-to-sales ratio of 0.35, the stock trades far below sector medians of 35.1 and 7.6. Trailing GAAP earnings per share of $4.71 are the basis for that multiple. The discount is steep enough to suggest the market doubts that current earnings will last, and it leaves the shares very sensitive to any sign that margins or growth are slipping. The company's net profit margin of 6.1% and operating margin of 9.56% are the figures investors will watch closely.

Revenue grew 297.50% in the latest quarter compared with the same quarter a year earlier, far ahead of the sector median growth of 24.2%. Return on equity of 32.37% is well above the sector median of 13.4%, and debt-to-equity of 0.57 is moderate. Analysts expect revenue to rise 97.8% this fiscal year to $77.3B. The business is growing and profitable on paper, which is why the company rates 4 of 5 for health.

Of 18 analysts with a current rating, 4 rate the stock buy or strong buy, 11 hold it and 3 sell it. Three months ago, 5 of 19 ratings were buys. The most recent actions include Rosenblatt keeping its Buy rating on October 21, 2026, and Citigroup and Mizuho keeping Neutral ratings in October. Insiders sold $62.8M of stock over the last 18 months across 12 sales and made no open-market purchases. Such sales are often planned in advance, so they are a weaker signal than purchases would be.

The base case is that the stock stays under pressure while it trades below both its 200-day and 50-day averages. Momentum is in the bearish zone and the MACD line is negative, so a durable recovery would need the price to first reclaim the 200-day SMA and the 20-day EMA, then the 50-day SMA. Analysts' estimates point to EPS growth of 74.0% this fiscal year, to $6.32, and a further 6.4% next year, to $6.72, so the fundamental story is still expanding. The median analyst target is $45.00 against a $15.00 low and a $60.00 high, but the rating mix is mostly Hold, with 11 of 18 analysts there. A better outcome would come if the next quarterly report again beats estimates and the shares hold above the 200-day SMA. A worse one would follow a miss, or a break below the 52-week low of $19.48, which would signal that the market is refusing to credit the earnings beats. Insider sales of $62.8M over the last 18 months, with no open-market purchases, add to the cautious tone.

Nearest support sits at the 52-week low of $19.48, the floor of the stock's trading range over the past year. Above the price, the first resistance is the 200-day SMA at $32.60, closely followed by the 20-day EMA at $32.83; these two sit together and form a zone the stock must clear before the trend can turn. The 50-day SMA at $37.27 is the next hurdle, and the 52-week high of $51.40 is the furthest level on the chart.